3,136
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study

, ORCID Icon, , ORCID Icon, , & show all
Pages 97-104 | Received 06 Apr 2018, Accepted 18 May 2018, Published online: 17 Jul 2018

References

  • Tanos V, Berry KE. Benign and malignant pathology of the uterus. Best Pract Res Clin Obstet Gynaecol. 2018;46:12–30.
  • Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990–1997. Obstet Gynecol. 2002;99:229–234.
  • Wise LA, Palmer JR, Stewart EA. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005;105:563–568.
  • Agdi M, Tulandi T. Endoscopic management of uterine fibroids Best Practise and Research. 2008;22:707–716.
  • Emanuel MH, Verdel MJC, Stas H. An audit of true prevalence of intra-uterine pathology: the hysteroscopical findings controlled for patient selection in 1202 patients with abnormal uterine bleeding. Gynecol Endosc. 1995;4:237–241.
  • Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99:290–300.
  • Guarnaccia MM, Rein MS. Traditional surgical approaches to uterine fibroids abdominal myomectomy and hysterectomy. Clin Obstet Gynecol. 2001;44:385–400.
  • Kim CH, Kim SR, Lee HA, et al. Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas. Hum Reprod. 2011;26:559–563.
  • Masciocchi C, Arrigoni F, Ferrari F, et al. Uterine fibroid therapy using interventional radiology mini-invasive treatments: current perspective. Med Oncol. 2017;34:52.
  • Sconfienza LM, Lacelli F, Gandolfo N, et al. Contrast-enhanced ultrasound (CEUS) assessment of superselective uterine fibroid embolization (SUFE): preliminary experience. JUS. 2008;11:158–161.
  • ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112:387–400.
  • Gabriel-Cox K, Jacobson GF, Armstrong MA, et al. Predictors of hysterectomy after uterine artery embolization for leiomyoma. Am J Obstet Gynecol. 2007;196:588.e1–586.
  • Jun Wu X, Guo Q, Sheng Cao B, et al. Uterine leiomyomas: safety and efficacy of US-guided suprapubic transvaginal radiofrequency ablation at 1-year follow-up. Radiology. 2016;279:952–960.
  • Ferrari F, Arrigoni F, Miccoli A, et al. Effectiveness of magnetic resonance‐guided focused ultrasound surgery (MRgFUS) in the uterine adenomyosis treatment: technical approach and MRI evaluation. Radiol Med. 2016;121:153–161.
  • Yang Y, Zhang J, Han Z, et al. Ultrasound-guided percutaneous microwave ablation for submucosal uterine fibroids. JMIG. 2014;21:437–441.
  • Feng B, Liang P, Cheng Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: Experimental and clinical studies. Eur J Endocrinol. 2012;166:1031–1037.
  • Baek JH, Lee JH, Sung JY, et al. Korean Society of Thyroid Radiology. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262:335–342.
  • Ritz JP, Lehmann KS, Schumann T, et al. Effectiveness of various thermal ablation techniques for the treatment of nodular thyroid disease-comparison of laser-induced thermotherapy and bipolar radiofrequency ablation. Lasers Med Sci. 2011;26:545–552.
  • Shin JH, Baek JH, Ha EJ, et al. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012;2012:919650.
  • Mauri G. Expanding role of virtual navigation and fusion imaging in percutaneous biopsies and ablation. Abdom Imaging. 2015;40:3238–3239.
  • Tomonari A, Tsuji K, Yamazaki H, et al. Feasibility of the virtual needle tracking system for percutaneous radiofrequency ablation of hepatocellular carcinoma. Hepatol Res. 2013;43:1352–1355.
  • Turtulici G, Orlandi D, Corazza A, et al. Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med Biol. 2014;40:1447–1452.
  • Orsi F, Monfardini L, Bonomo G, et al. Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: do we need the microbubbles? Int J Hyperthermia. 2015;31:233–239.
  • Orlandi D, Sconfienza LM, Lacelli F, et al. Ultrasound-guided core-needle biopsy of extra-ocular orbital lesions. Eur Radiol. 2013;23:1919–1924.
  • Walter CB, Hartkopf AD, Schoeller D, et al. Ultrasound guided core needle biopsy prior to thermo ablative treatment of uterine tumors: first results. Arch Gynecol Obstet. 2018;297:387–392.
  • DeLonzor R, Spero RK, Williams JJ. The electrical conductivity of in vivo human uterine fibroids. Int J Hyperthermia. 2011;27:255–265.
  • Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. J Vasc Interv Radiol. 2014;25:1691–1705.
  • Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11–17.
  • Havryliuk Y, Setton R, Carlow JJ, et al. Symptomatic fibroid management: systematic review of the literature. JSLS. 2017;21:pii:00041.
  • Leslie TA, Kennedy JE. High intensity focused ultrasound in the treatment of abdominal and gynaecological diseases. Int J Hyperthermia. 2007;23:173–182.
  • Orlandi D, Turtulici G. Reply regarding Virtual navigation and fusion imaging in percutaneous ablations in the neck. Ultrasound Med Biol. 2015;41:899.
  • Lee BB, Yu SP. Radiofrequency ablation of uterine fibroids: a review. Curr Obstet Gynecol Rep. 2016;5:318–324.
  • Hai N, Zhang J, Xu R, et al. Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience. IJH. 2017;33:646–652.
  • Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23:1044–1049.
  • Mauri G, Cova L, Monaco CG, et al. Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). IJH. 2016;15:1–5.
  • Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20:11–22.
  • Shyn PB, Mauri G, Alencar RO, et al. Percutaneous imaging-guided cryoablation of liver tumors: predicting local progression on 24-hour MRI. AJR Am J Roentgenol. 2014;203:W181–W191.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39:1023–1030.
  • Mauri G, Porazzi E, Cova L, et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5:209–216.
  • Prada F, Bene MD, Fornaro R, et al. Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. Neurosurg Focus. 2016;40:E7.
  • Prada F, Vitale V, Del Bene M, et al. Contrast-enhanced MR imaging versus contrast-enhanced US: a comparison in glioblastoma surgery by using intraoperative fusion imaging. Radiology. 2017;285:242–249.
  • Mauri G, Cova L, De Beni S, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38:143–151.
  • Mauri G, Nicosia L, Varano GM, et al. Tips and tricks for a safe and effective image-guided percutaneous renal tumour ablation. Insights Imaging. 2017;8:357–363.